Clopidogrel inhibits platelet aggregation, indirectly reducing thrombin generation. This is crucial in preventing thrombotic events in patients with clotting disorders.

Clopidogrel reduces thrombin generation by limiting platelet activation. This decreases the risk of strokes and heart attacks in clotting disorder patients.